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Abstract
Background: To analyse histological composition and progression of carotid plaque.
Methods: Thirty-one patients (22 males, mean age 68.03 ± 7.3 years) admitted for carotid
endarterectomy for extracranial high-grade internal carotid artery stenosis (≥ 70% luminal
narrowing) were enrolled. The patients were divided into 2 groups according to symptomatology
(group I, 17 symptomatic patients; and group II, 14 asymptomatic patients). A histological analysis
and inflammatory cell quantification of each excised carotid plaque was made. Nine carotid arteries
were removed from human cadavers that were not preselected for carotid artery disease. These
specimens were used as a control tissue without any macroscopic signs of atherosclerotic plaques.
Results: Fifty eight percent of all carotid plaques were classified as complex plaque with possible
surface defect, hemorrhage or thrombus. The inflammatory cells concentration did not differ
between the two groups. All specimens from human cadavers were classified as preatheroma with
extracellular lipid pools.
Conclusion: Asymptomatic and symptomatic patients could have the same histological
components on their carotid plaques. Fibrotic and calcific plaques could become vulnerable as
complex plaques with surface defect, hemorrhage and thrombus could remain silent.
Asymptomatic carotid stenosis should be followed close with no invasive diagnostic methods and
clinical evaluation.
Background
In 1995, a report from the Committee on Vascular Lesions
of the Council on Atherosclerosis, American Heart Associ-
ation (AHA), had described the characteristic components
and pathogenic mechanisms of the various advanced
atherosclerotic lesions [1]. This report provides a classifi-
cation of human atherosclerotic lesions based on their
histological composition and structure and reflects the
temporal natural history of disease. The lesions were clas-
sified by Roman numerals that indicate the usual
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sequence of lesion progression, grading from type I (ini-
tial lesions) to type VIII (fibrotic plaque). Varying propor-
tions of different components (connective tissue
extracellular matrix; crystalline cholesterol, cholesteryl
esters, phospholipids; and cells such as monocyte-derived
macrophages, T lymphocytes, and smooth muscle cells)
occur in different plaques, thus giving rise to a spectrum
of lesions [2,3]. Surface defects, hematoma, and throm-
botic deposits futher damage, deform, and thicken, and
accelerate conversion from clinically silent to overt dis-
ease [1]. The present study was designed to characterize
the progression and composition of carotid plaque,
according with patient symptomatology, based on the
American Heart Association (AHA) classification for
human atherosclerotic lesions [1,4]. The inflammatory
cell quantification was based on estereology method.
Methods
A. Patients
Thirty-six nonconsecutive surgical inpatients admitted for
carotid endarterectomy for extracranial high-grade (≥
70%) internal carotid artery stenosis were entered into
this study between February 2003 and July 2005 from 3
participating hospitals. Local ethical committee approval
was obtained for the study and procurement of speci-
mens. Written informed consent was obtained from all
patients. Exclusion criteria were: a disorder that could seri-
ously complicate surgery (3 patients); terminal cancer (1
patient); and patient refusal of operation (1 patient). The
study was conducted on 31 common or internal carotid
artery plaques from the 31 remaining patients (22 men
and 9 women; mean age 68.03 ± 7.3 years). A clinical
examination, including neurological exam, with particu-
lar care taken to establish the number and duration of
ischemic events, and a record of the time from the last
symptom and the operation, was obtained from each
patient. Before surgery, all patients underwent a: 1 – either
cerebral angiography or magnetic resonance angiography
and Duplex ultrasound for grading carotid artery stenosis
and assessment of intracranial arterial system; and 2 –
either computer tomography (CT) or magnetic resonance
brain scan. The presence or absence of infarction in the
corresponding middle cerebral artery territory was noted.
Focal cerebral ischemic events were defined as transient
ischemic attack (TIA), amaurosis fugax (AF), central reti-
nal artery occlusion (CRAO), or cerebrovascular accident.
Patients were considered to be symptomatic if they had
experienced AF, TIA or stroke ipsilateral to the carotid
lesion being studied. Silent infarcts and lacunar symp-
tomatology, diagnosed by a neurologist based on clinical
and brain computer tomography (CT) scan and/or mag-
netic resonance imaging (MRI) located ipsilateral to the
stenosis, were also considered symptomatic. On the other
hand, patients without any history of recent neurologic
symptoms or with nonspecific, nonhemispheric symp-
toms such as dizziness and vertigo were considered
asymptomatic. Each patient was then assigned preopera-
tively to 1 of 2 groups on the basis of their symptom:
group I (n = 17; mean age 66 ± 7 years) symptomatic
patients; and group II (n = 14; mean age 67.6 ± 6.81 years)
consisting of all asymptomatic patients. At the baseline
examination, measurements of height, weight, body mass
index, blood pressure, fasting serum total cholesterol,
HDL cholesterol, LDL cholesterol, triglycerides, fasting
plasma glucose, electrocardiograms and information
about coronary artery disease, diabetes mellitus and
smoking habits was collected. Percentages of carotid
diameter reduction, procedural methods, concomitant
therapy, age, sex, and risk factors did not differ between
the 2 groups (Table 1). Nine carotid arteries were removed
from human adult cadavers that were not preselected for
carotid artery disease. These specimens were used as a con-
trol tissue without any macroscopic signs of atheroscle-
rotic plaques.
Table 1: Patient's Characteristics
Group I (n = 17) (symptomatic) Group II (n = 14) (asymptomatic)
Age, years 66.6 ± 6.7 67.6 ± 6.81
Sex, M/F 12/5 9/5
Hypertension 12 13
Diabetes mellitus 6 3
Active Smoking 5 4
Hypercholesterolemia 4 3
CAD 4 4
Aspirin 17 14
Statin 6 5
ACE inhibitors 10 10
Ticlopidine 4 1
CAD = coronary artery disease
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B. Procurement of tissue specimens and histological 
analysis
Carotid plaques were obtained immediately after endar-
terectomy. All surgeries were performed with standard
surgical techniques, and with minimal manipulation of
the specimen. No attempts were made to evaluate the
presence and the degree of surface ulceration or throm-
bus. The plaque should be removed in bloc, without frag-
mentation or significant distortion. After removal, the
section of plaque for histological analysis was placed in
fresh 4% paraformaldehyde solution and partly decalci-
fied overnight, in order to be sectioned subsequently. The
samples were transected transversely at 3 to 4 mm, and
embedded in paraffin. For the most of the specimens, five
to six blocks were avaiable. Histological analysis was per-
formed by an experience pathologist (SGR), based on
American Heart Association classification for human
atherosclerotic lesions [3,4]. The inflammatory cell quan-
tification was assessed by light microscopy with final mag-
nification of 400 ×, using an ocular lens with a grid
graticule. The observer selected a region in the plaque sec-
tion with as many inflammatory cells as possible (hot
spot). When no inflammatory area was clearly identified
the selection was made in an aleatory way. Total area
examined was 0.6 mm2 and each graticule grid corre-
sponds to an area of 0,0625 mm2 with magnification of
400 ×. The inflammatory cells were counted in 10 differ-
ent graticule area in each specimen. The human carotid
arteries removed from cadavers had received the same his-
tological treatment.
Statistical analysis
Continuous variables were expressed as mean ± SD. Statis-
tical significance was indicated by a value of P < 0.05. The
comparison of the histological parameters among the
groups was done by non-parametric test of Kruskal-Wallis.
Results
The histological analysis according to AHA classification
for human atherosclerotic lesions is disposed in Table 2.
Fifty eight percent of all carotid plaques were classified as
Type VI of AHA. All the carotid arteries removed from
human cadavers were classified as Type III (preatheroma
with extracellular lipid pools). The inflammatory cells
counting did not differ between the groups and between
the plaque types, varying from 0 to 109 cells by specimen.
Figures 1 and 2 are examples of types III, IV, V, VI, VII and
VIII of AHA classification.
Discussion
An asymptomatic patient with carotid artery stenosis is
always a reason of concern for his personal physician.
Table 2: American Heart Association Classification for human atherosclerotic lesions according clinical groups.
Group I (n = 17) (symptomatic) Group II (n = 14) (asymptomatic)
Type IV 2 0
Type V 4 2
Type VI 7 11
Type VII 2 0
Type VIII 2 1
Inflammatory cells 0–109 0–88
(minimum - maximum/specimen - median ± sd) (22 ± 28) (26 ± 29)
Left panel: Cadaver carotid arteryFigure 1
Left panel: Cadaver carotid artery. Type III AHA. Preatheroma with extracellular lipid pools (blue area in the center). Mid 
panel: Type IV AHA. Atheroma with confluent extracellular lipid core (pink area in the center). Right panel: Type V AHA. 
Fibroatheroma (clearer pink area – atheroma – surrounded by darker pink area – fibrosis).
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Current AHA guidelines recommended carotid endarter-
ectomy (CEA) for asymptomatic patients, for stenosis
60% to 99%, if the risk of perioperative stroke or death is
less than 3%. However, factors in addition to the degree
of stenosis, such as the histological composition of the
plaque, may be responsible for the determination of
stroke risk. The mature atherosclerotic plaque is a com-
plex structure suffering constantly of reparative process
and its histological characterization is not easy. It was
expected that types IV (atheroma with confluent extracel-
lular lipid core), V (fibroatheroma) and VI (complex
plaque with possible surface defect, hemorrhage or
thrombus) of AHA classification should be the only ones
found in group I (symptomatic patients), but we had clas-
sified two patients as having type VII (calcified plaque),
and two patients as type VIII (fibrotic plaque). Also, in
group II (asymptomatic patients) we found 11 patient as
having plaques type VI. The fact that all surgical specimens
in the present study had a high grade of complexity shows
the challenge to try to separate vulnerable from stable
carotid plaques. In the early stages of atherosclerosis the
sequence is predictable, characteristics, and uniform, as
we could evidence in the carotid arteries removed from
human cadavers. However, lesions may subsequently
progress in different morphogenetic sequences, resulting
in several characteristic lesion types and clinical syn-
dromes [1]. It is well known that vulnerable plaques con-
tain more total lipid and cholesterol, and less collagen
and calcium as we could demonstrate in previous study
[5-8]. However, the present study had evidenced that the
atherosclerotic plaque is not a one-way progression from
a "soft" to a "hard" plaque. When or why some these
plaques will cross the line between stable to vulnerable?
We know that fissures can occur in fibrotic and calcific
plaques making then more vulnerable and the present
study had evidenced that inflammatory cells are a con-
stant part of atherosclerotic process, even in asympto-
matic patients. The answer probably will be in the
imunohistochemical analysis [9-14]. Most we have
learned about vulnerable plaques is from imaging meth-
ods (ultrasound, magnetic resonance, and tomography)
that wants to predict vascular events [15-29]. All these
methods are able to identify precisely different propor-
tions of fibrous tissue, lipid tissue and calcium as we had
demonstrated in previous study [5]. Some methods,
mainly ultrasound tissue characterization can classify het-
erogeneous tissues based on second order statiscal param-
eters (entropy, homogeneity and energy) but they are
failed in determine what this heterogeneous finds really
means. Are they related with intrinsic reparative process
inside the plaques? All these considerations suggest that
asymptomatic carotid stenosis should be followed close
with no invasive diagnostic methods and clinical evalua-
tion.
Study limitations
First, the small number of patients was an important study
limitation. This limitation will not be easily overcome,
since the improvement of carotid artery stenting tech-
niques will make histological analysis of carotid plaques
an infrequent procedure. Second, by necessity, the
plaques were sectioned and only a small proportion of
each plaque was examined microscopically, and it may
well be that features were missed in some patients. Most
large lesions vary in composition along their length. This
may particularly apply to the classification of fibrotic and
calcific plaques in group I, where probably different com-
ponents were missed when a small number of individual
sections were examined. Third, we considered in this
study patients with lacunar infarctions (LI) as had symp-
tomatic carotid plaques. According to Tejeda et al [8],
although significant carotid stenosis was observed at
Left panel: Type VI AHAFigure 2
Left panel: Type VI AHA. Complex plaque with possible surface defect, hemorrhage (dotted red area) or thrombus near the 
lipid core (in the center). Mid panel: Type VII AHA. Calcified plaque (purple areas). Right panel: Type VIII AHA. Fibrotic plaque 
without lipid core (extensive area of fibrosis).
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lower levels in LI, its pathogenic value should be taken
into account because, when detected on the symptomatic
side, it is not only a marker of atheromatosis but also a
process potentially linked to LI. And finally, we did not
perform imunohistochemical analysis in the present
study that would certainly differentiate more instable
carotid plaques, with large macrophage infiltration.
Conclusion
Mature carotid plaques are complex structures and their
histological classification is a real challenge. Asympto-
matic and symptomatic patients could have the same his-
tological components on their carotid plaques. Fibrotic
and calcific plaques could become vulnerable as complex
plaques with surface defect, hemorrhage and thrombus
could remain silent. Asymptomatic carotid stenosis
should be followed close with no invasive diagnostic
methods and clinical evaluation.
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